Pervasis Therapeutics Lands $12,000,000 Series B Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6f3e092d-0c79-410e-a304-3e4e505c4478&Preview=1 -
Date
9/30/2005 -
Company Name
Pervasis Therapeutics -
Mailing Address
One Kendall Square, Building 600 Cambridge, MA 02139 -
Company Description
Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease. -
Website
http://www.pervasistx.com -
Transaction Type
Venture Equity -
Transaction Amount
$12,000,000 -
Transaction Round
Series B -
Proceeds Purposes
The financing will be used to continue clinical development of the company’s first product, a combination device for patients with vascular disease. -
M&A Terms
-
Venture Investor
Polaris Venture Partners -
Venture Investor
Highland Capital Partners -
Venture Investor
Flagship Ventures
